KKR and CDH Investments have agreed to sell HK$1.87 billion ($241.5 million) worth of shares in China Modern Dairy – which will see them fully exit a position they received when selling part of a greenfield cattle farming joint venture to Modern Dairy in 2015.
China Mengniu Dairy will acquire 965.5 million shares in Modern Dairy from the two PE firms for HK$1.94 apiece, a 3.2% premium to the January 3 closing price, according to a filing. Its stake in the business...
Even if pan-Asian buyout firms aren't actively pursuing investments in internet-related businesses, they cannot ignore the potential disruptive impact of these technologies on other portfolio companies
Mekong Capital's 6.3x return on its investment in Vietnam-based pharmaceuticals player Traphaco involved turning the company's distribution model on its head, as well as supporting expansion and improving governance
China Renaissance has added dedicated healthcare and mezzanine debt strategies to its existing growth-stage private equity offering as part of efforts to more than treble its assets under management (AUM) over the next three years.
China Venture Capital Fund, a VC vehicle backed by the Chinese government, and ChinaEquity Group have jointly led a RMB670 million ($101 million) round for 3D Medicines, which focuses on personalized diagnostics and treatment for cancer.